Procter & Gamble Company (The) (NYSE:PG) has received a consensus recommendation of “Hold” from the twenty-two ratings firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and ten have issued a buy rating on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $89.39.

PG has been the topic of a number of recent analyst reports. Deutsche Bank AG reiterated a “hold” rating and issued a $92.00 price objective (up previously from $90.00) on shares of Procter & Gamble Company (The) in a research report on Saturday, July 22nd. Zacks Investment Research cut Procter & Gamble Company (The) from a “buy” rating to a “hold” rating in a research report on Thursday, August 3rd. BidaskClub upgraded Procter & Gamble Company (The) from a “hold” rating to a “buy” rating in a research report on Saturday, August 19th. Vetr lowered Procter & Gamble Company (The) from a “hold” rating to a “sell” rating and set a $83.75 target price on the stock. in a research note on Monday, July 3rd. Finally, Macquarie assumed coverage on Procter & Gamble Company (The) in a research note on Thursday, September 14th. They issued an “outperform” rating and a $102.00 target price on the stock.

COPYRIGHT VIOLATION WARNING: “Procter & Gamble Company (The) (PG) Receives $89.39 Average PT from Brokerages” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/03/procter-gamble-company-the-pg-receives-89-39-average-pt-from-brokerages.html.

In other Procter & Gamble Company (The) news, SVP Valarie L. Sheppard sold 20,175 shares of the stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $92.65, for a total transaction of $1,869,213.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Suranjan Magesvaran sold 10,512 shares of the firm’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $91.00, for a total transaction of $956,592.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 45,792 shares of company stock worth $4,216,070. 0.35% of the stock is owned by corporate insiders.

Several large investors have recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in Procter & Gamble Company (The) by 2.3% during the 2nd quarter. Vanguard Group Inc. now owns 180,730,770 shares of the company’s stock valued at $15,750,688,000 after purchasing an additional 4,066,266 shares during the period. BlackRock Inc. raised its position in Procter & Gamble Company (The) by 1.4% during the 2nd quarter. BlackRock Inc. now owns 156,361,011 shares of the company’s stock valued at $13,626,862,000 after purchasing an additional 2,164,426 shares during the last quarter. Trian Fund Management L.P. raised its position in Procter & Gamble Company (The) by 2.4% during the 2nd quarter. Trian Fund Management L.P. now owns 37,612,012 shares of the company’s stock valued at $3,277,887,000 after purchasing an additional 893,157 shares during the last quarter. American Century Companies Inc. raised its position in Procter & Gamble Company (The) by 8.1% during the 2nd quarter. American Century Companies Inc. now owns 12,490,795 shares of the company’s stock valued at $1,088,573,000 after purchasing an additional 934,179 shares during the last quarter. Finally, Capital Research Global Investors raised its position in Procter & Gamble Company (The) by 74.2% during the 2nd quarter. Capital Research Global Investors now owns 12,389,104 shares of the company’s stock valued at $1,079,710,000 after purchasing an additional 5,278,359 shares during the last quarter. 59.30% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Company (NYSE:PG) traded up 0.38% during midday trading on Friday, reaching $92.12. The company’s stock had a trading volume of 5,909,908 shares. Procter & Gamble Company has a 12 month low of $81.18 and a 12 month high of $94.67. The company has a market cap of $234.91 billion, a PE ratio of 16.47 and a beta of 0.67. The stock has a 50-day moving average price of $92.59 and a 200 day moving average price of $89.70.

Procter & Gamble Company (The) (NYSE:PG) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.85 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.78 by $0.07. Procter & Gamble Company (The) had a return on equity of 19.97% and a net margin of 23.56%. The firm had revenue of $16.08 billion for the quarter, compared to analysts’ expectations of $16.01 billion. During the same period in the prior year, the business posted $0.79 earnings per share. The company’s revenue was down .1% on a year-over-year basis. Analysts expect that Procter & Gamble Company will post $4.17 earnings per share for the current fiscal year.

About Procter & Gamble Company (The)

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.

Analyst Recommendations for Procter & Gamble Company (The) (NYSE:PG)

Receive News & Stock Ratings for Procter & Gamble Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble Company (The) and related stocks with our FREE daily email newsletter.